Natco Pharma Limited

NATCOPHARM
1,186.00trending_up+1.11%May 26, 2026

Price History

Loading...

Recent Discussions

AM
Arjun Mehta7d ago

Natco Pharma investors should note that the company's annual results for the fiscal year 2026 will be reviewed during a board meeting on May 29, 2026. The trading window will close on May 19, 2026, and won't reopen until 48 hours after the results have been announced.

PS
Prakash Shah7d ago

Today, several stocks are generating interest, such as Adani Group, JSW Cement, Eicher Motors, Vascon Engineers, Captain Polyplast, Veerhealth Care, and Natco Pharma. These companies' performance is drawing attention from investors.

KN
Kavya Nair11d ago

Natco Pharma has received a notice worth INR 4.92 crores from NPPA, alleging overpricing for certain period between April and November 2023. However, the company's overall financial performance and operations remain unaffected due to this notice.

VV
Vivek Verma13d ago

Natco Pharma appears to be regaining traction, as it has retested its ascending channel support and exhibits a bullish MACD crossover. Additionally, the Stochastic RSI has climbed out of oversold territory, while higher lows with increased volume on bounces indicate potential growth.

RS

Natco Pharma hit a new 52-week high, leading the rally of momentum stocks. Other companies such as Thermax, Finolex Cables, Craftsman, and Netweb also experienced notable gains.

RS
Raman Srivastava30d ago

Natco Pharma has broken out of a long period of consolidation, suggesting a positive trend ahead. The breakout occurred with increased trading volume near a significant demand area, indicating growing interest. The stock's relative strength and price holding above the breakout point signal potential for further gains.

TM
Tarun Mathur35d ago

Foreign institutional investors (FIIs) have shown increased confidence by increasing their stakes in small-cap stocks like Bajaj Corp and Natco Pharma. This move comes after both companies reported significant revenue growth in their recent quarters – Bajaj Corp saw a 31% year-over-year increase, while Natco Pharma experienced a 36% jump in revenue and a 14% profit growth during Q3 FY26.

PS
Prakash Shah49d ago

Anand Rathi's Jigar Patel suggests Birlasoft, Natco Pharma, and GAEL as potential stocks for short-term profit due to identified favorable buying points. Meanwhile, the Nifty 50 and Bank Nifty indices show mixed directions, with significant levels of 23,100 for Nifty and 52,500 for Bank Nifty requiring confirmation for future trends.